New test could speed up deadly fungus diagnosis in ICU patients
NCT ID NCT03469401
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether measuring a substance called BD glucan in the abdominal fluid of ICU patients with peritonitis can diagnose fungal infections faster than standard lab cultures. Fungal peritonitis is deadly, and current tests take at least 48 hours. The study enrolled 126 adults in intensive care to compare the new test's accuracy against traditional methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BD glucan detection test (Fungitell)
What this could lead to
If successful, this could lead to faster diagnosis of fungal peritonitis, allowing earlier treatment and potentially reducing deaths.
What could go wrong
This is a completed diagnostic study, not a treatment trial. The test may not be accurate enough to replace current methods, and results may not apply to all ICU patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, France